"Experts Push For Transgender Health Priorities In Congressional Briefing" - Regina Schaffer
There is a “durable, biological underpinning” to gender identity that should be considered in any policy determinations that impact transgender people, including antidiscrimination legislation and the coverage of medically necessary treatments for gender incongruence, according to several speakers at an Endocrine Society congressional briefing on transgender health. Despite years of growing awareness of transgender people, and even transgender celebrities, only recently has a noticeable shift begun among the public regarding how to best approach treating people with gender incongruence, said Joshua Safer, MD, executive director of the Center for Transgender Medicine and Surgery at Mount Sinai, during a briefing. That shift, he said, is due in part to an increasing evidence base that points to the biological underpinnings of gender identity. “The establishment medical community recognizes better than it ever did before the biology of gender identity,” Dr. Safer said.
- Joshua Safer, MD, Executive Director of The Center for Transgender Medicine and Surgery at Mount Sinai, Senior Faculty, Endocrinology, Icahn School of Medicine at Mount Sinai